Jane, E. P., Premkumar, D. R., Cavaleri, J. M., Sutera, P. A., Rajasekar, T., & Pollack, I. F. (2016). Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines. J Pharmacol Exp Ther.

Jane, Esther P., Daniel R. Premkumar, Jonathon M. Cavaleri, Philip A. Sutera, Thatchana Rajasekar, and Ian F. Pollack. "Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines." J Pharmacol Exp Ther 2016.

Jane, Esther P., et al. "Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines." J Pharmacol Exp Ther 2016.